Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer [Phase 2, Phase 3]
Phase 2/3 trial update assessing comprehensive geriatric management to reduce morbidity and improve quality of life in elderly patients unde…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer [Phase 2]
This update outlines a Phase 2 clinical trial evaluating the combination of SGT-53 with gemcitabine and nab-paclitaxel for metastatic pancre…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients [Phase 2]
Phase 2 trial evaluating modified FOLFIRINOX as adjuvant chemotherapy for pancreatic cancer in Chinese patients; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors [Phase 1]
Phase 1 trial evaluating safety and biomarker signals for DK210, an EGFR-targeting therapy, across multiple EGFR-positive solid tumors; curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer [Phase 1]
A Biogen-sponsored Phase 1 study evaluating gemcitabine with RTA 402 (bardoxolone methyl) in patients with unresectable pancreatic cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating surufatinib in combination with TAS-102 for advanced pancreatic cancer in third-line and beyond has completed.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer [EARLY_Phase 1]
A first-in-human early-phase study of a theranostic pair using Ga-68 DOTA-5G and Lu-177 DOTA-ABM-5G for pancreatic cancer is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
This clinical trial assesses the diagnostic capacity of extrachromosomal circular DNAs (eccDNAs) as biomarkers for indeterminate biliary str…
-
CLINICAL_TRIALS other · 2025-05-28Clinical Trial Update: Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004) [Phase 2]
Phase 2 trial evaluating Ivonescimab in combination with Gemcitabine and Nab-paclitaxel (GnP) and SBRT for metastatic pancreatic cancer; the…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated stereotactic body radiation therapy with 5-fluorouracil or capecitabine for locally advan…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating Th-1 dendritic cell immunotherapy in combination with standard chemotherapy for pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Proglumide and Chemotherapy for Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating proglumide in combination with chemotherapy for metastatic pancreatic cancer, with the study currentl…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: CEB-01 in Locally Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial update for CEB-01 in locally resectable pancreatic cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors [EARLY_Phase 1]
Early-phase study evaluating ABO2102, a KRAS neoantigen mRNA vaccine, in KRAS-mutated solid tumors including pancreatic cancer; recruitment …
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer
Minia University is sponsoring a clinical trial comparing immediate surgery versus neoadjuvant chemotherapy for resectable pancreatic cancer…
-
FDA approval · 2025-05-15FDA Approved: PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) — Original Application (BluePoint Laboratories)
FDA approved the original application for paclitaxel protein-bound particles for injectable suspension (albumin-bound) from BluePoint Labora…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer [Phase 3]
Phase 3 trial assessing intraoperative celiac plexus neurolysis in patients with operable pancreatic and periampullary cancer; study status …
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study [NA]
The RT-CAMSS study, a real-time monitoring trial of chemotherapy side-effects in gastrointestinal cancers, has completed.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer [Phase 1]
A Phase 1 study of armed, activated T-cells for advanced pancreatic cancer is currently active but not recruiting.